CLINICAL_TRIALS
trial_result
· 2016-06-06
Clinical Trial Update: Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study [Phase 2, Phase 3]
Summary
The A.C.T Study reports completion of Phase 2/3 trials evaluating intravitreal aflibercept injections for proliferative diabetic retinopathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ophthalmic Consultants of Long Island | Conditions: Proliferative Diabetic Retinopathy | Phase 2, Phase 3 | Status: COMPLETED